Table of Contents
Washington University Experience | NEOPLASMS (HEMATOLYMPHOID) | Lymphoma, secondary | 6C1 Lymphoma, secondary (Case 6) CD20 2.jpg
6C1-3 Immunohistochemically stained sections show strong reactivity within tumor cells for B-cell markers CD20 (6C1) and CD79A (6C2).
